World Allergy Organization Concludes
1st WAO Symposium on Immunotherapy and Biologics
in Chicago, IL, United States
 |
|
|
Chairs of the WAO Symposium: |
From 13-14 December 2013 in Chicago, IL, United States, 390 attendees from 40 countries gathered for the first WAO Symposium on Immunotherapy and Biologics. A faculty of 40 internationally recognized experts reported on therapeutic advances, clinical breakthroughs, and research needs related to the diagnosis, treatment, and prevention of allergic diseases and asthma which now affect 30-40% of the world’s population. The Symposium’s main focus was on the current advances and future research needs in immunotherapy and biologics and their impact on understanding and treating increasingly complex allergic diseases and asthma in the individual patient.
Experts elaborated on topics in personalized medicine in allergy and asthma during sessions of the “Biologics Track” and the “Immunotherapy Track”. Delegates had opportunities to attend a keynote lecture on personalized medicine and a special lecture on molecular mechanisms and the treatment of hereditary angioedema and to receive information about key documents nearing publication including the 2013 update of the “Sublingual Immunotherapy: World Allergy Organization Position Paper”, the 2013 update of the WAO White Book on Allergy, and an update on the Urticaria Guidelines presented by WAO and the American Academy of Allergy Asthma and Immunology. The scientific program also featured two poster sessions, presenting 50 accepted abstracts.
For more information, visit the Online Scientific Program.
